Registration for a live webinar on 'Phasing Out Animal Testing: A New Era for Pharmaceutical Innovation' is now open.
See webinar details
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- Luminal Gastroenterology
-
31 min
1. Novel treatments for GI malignancies- Prof. Bert H. O'Neil
-
40 min
2. The spectrum of GERD implications for assessment and management- Prof. Eamonn M. M. Quigley
-
54 min
3. Oro-pharyngeal and esophageal motility and dysmotility- Dr. John E. Pandolfino
-
55 min
4. Eosinophilic esophagitis and other non-reflux esophageal disorders- Prof. David Katzka
-
39 min
-
17 min
-
48 min
-
48 min
8. Gastric cancer, gastritis and the role of H. pylori- Prof. Anthony Axon
-
48 min
9. Celiac disease- Prof. Ciaran Kelly
-
43 min
10. IBD for the non-gastroenterologist- Prof. Sunanda Kane
-
34 min
11. The enteric microbiota in health and disease- Dr. Francisco Guarner
-
45 min
12. Colorectal cancer and hereditary colon cancer syndromes- Prof. Carol A. Burke
-
39 min
13. The spectrum of GI ischemia 1- Prof. Lawrence J. Brandt
-
31 min
14. The spectrum of Gl ischemia 2- Prof. Lawrence J. Brandt
-
41 min
15. Constipation and defecation disorders- Prof. Satish S. C. Rao
-
40 min
16. Diverticular disease of the colon- Dr. Dale Vimalachandran
-
73 min
17. Irritable bowel syndrome (IBS)- Prof. Eamonn M. M. Quigley
-
27 min
18. Evidence-based management of non-variceal upper GI bleeding- Prof. Joseph J. Sung
- Hepatology
-
32 min
19. Hepatitis B virus (HBV)- Prof. Marco Olivera-Martinez
-
26 min
20. Hepatitis C - cure of infection- Prof. Mark Mailliard
-
46 min
21. Drug-induced liver injury: importance, epidemiology, and mechanisms of DILI- Prof. James H. Lewis
-
26 min
22. Drug-induced liver injury: risk factors and drug development in DILI- Prof. James H. Lewis
-
39 min
23. Drug-induced liver injury: HDS, diagnosing, treating and preventing DILI- Prof. James H. Lewis
-
22 min
24. Portal hypertension- Prof. John Reinus
-
55 min
25. Portal hypertension: at the bedside- Dr. Clara Y. Tow
-
29 min
26. The management of chronic liver disease, including transplantation 1- Prof. Timothy M. McCashland
-
21 min
27. The management of chronic liver disease, including transplantation 2- Prof. Timothy M. McCashland
-
34 min
28. Hereditary hemochromatosis: what have we learnt from population studies- Prof. John K. Olynyk
-
38 min
29. Immune-mediated liver disease- Dr. Jenny Heathcote
-
51 min
30. Alcoholic liver disease- Prof. Michael Lucey
- The Pancreas and Biliary Tree
-
46 min
31. Acute pancreatitis- Prof. Davor Štimac
-
49 min
32. Chronic pancreatitis- Prof. Christopher Forsmark
-
47 min
33. Pancreatic cancer- Prof. Randall Brand
-
20 min
- Archived Lectures *These may not cover the latest advances in the field
-
52 min
35. The management of other aspects of chronic liver disease, including transplantation- Prof. Timothy M. McCashland
-
38 min
36. Chronic viral hepatitis B and C- Prof. Mark Mailliard
-
41 min
37. Pancreatic cancer- Prof. Randall Brand
-
72 min
38. Acute viral hepatitis- Prof. Geoffrey Dusheiko
-
33 min
39. Diverticular disease- Dr. Charles Knowles
-
57 min
40. The spectrum of gastrointestinal ischemia: 2010- Prof. Lawrence J. Brandt
-
51 min
41. Acute pancreatitis- Prof. Davor Štimac
Printable Handouts
Navigable Slide Index
- Introduction
- Lecture outline
- Eosinophilic esophagitis
- Eosinophilic esophagitis - definition
- Eosinophilic esophagitis - histology
- Pathogenesis of EE - basic science allergy
- Pathogenesis EE - human association allergy
- Pathogenesis of EE - human data
- Eosinophilic esophagitis - a 10 year experience
- Pathophysiology of EE: genetics
- A schematic summary of EE pathogenesis
- Diagnosis of EE
- Symptoms and endoscopic findings in EE (1)
- Dysphagia in EE
- Common endoscopic findings in EE patients
- Symptoms and endoscopic findings in EE (2)
- Effects of age on endoscopic symptoms of EE
- Eosinophils in the esophagus
- Proton pump inhibition effects in EE patients
- Difficulties in distinguishing GERD from EE
- EE may respond to proton pump inhibitors
- Potential blood biomarkers of EE
- Using histology to distinguish EE from GERD
- Eosinophils degranulation
- Novel histologic evaluation of mucosal biopsies
- EPX staining distinguishes EE from GERD
- Differentiating EE from GERD
- ROC curve for differentiating EE from GERD
- Potential therapies for EE
- Steroids and EE
- Efficacy of fluticasone and EE
- Mepolizumab (anti-IL-5) and EE
- Elemental diet and EE
- Allergy Rx and EE
- Endoscopy in EE and perforation risk
- Perforated esophagus
- Dilation and EE
- Treatment questions in EE
- Other esophageal diseases
- Lichen planus of the esophagus (1)
- Multiple strictures in Lichen planus
- Lichen planus of the esophagus (2)
- Skin diseases and the esophagus
- Infections of the esophagus
- The esophagus in systemic disease
- Scleroderma esophagus
- Medications associated w. esophageal injury
- Pill induced esophagitis
- Caustic ingestion of the esophagus
- Intramural diverticulosis
- Dysphagia lusoria
- Granular cell tumors
Topics Covered
- Eosinophilic esophagitis
- Mechanisms of allergy-induced esophagitis
- Risk of esophageal ring and stricture formation
- Effect of steroids on allergy-based esophagitis
- Safety and efficacy of dilation of eosinophilic esophagitis strictures
- Pathogenesis of inflammation and fibrosis in eosinophilic esophagitis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Katzka, D. (2011, January 5). Eosinophilic esophagitis and other non-reflux esophageal disorders [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved March 28, 2025, from https://doi.org/10.69645/WXWM5663.Export Citation (RIS)
Publication History
- Published on January 5, 2011
Financial Disclosures
- Prof. David Katzka has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.
Eosinophilic esophagitis and other non-reflux esophageal disorders
Published on January 5, 2011
55 min
